Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Amanda Dixon‐McIver"'
Autor:
Amanda Dixon-McIver, Phil East, Charles A Mein, Jean-Baptiste Cazier, Gael Molloy, Tracy Chaplin, T Andrew Lister, Bryan D Young, Silvana Debernardi
Publikováno v:
PLoS ONE, Vol 3, Iss 5, p e2141 (2008)
Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults; however, the genetic aetiology of the disease is not yet fully understood. A quantitative expression profile analysis of 157 mature miRNAs was performed on 100 AML patients r
Externí odkaz:
https://doaj.org/article/18c2a0160e454ae58547d7a035fe6355
Autor:
Janet L, Pitman, Arthur J, Morris, Stephen, Grice, Joseph T, Walsh, Leyi, Wang, Martin D, Burke, Amanda, Dixon-McIver
Publikováno v:
The New Zealand medical journal. 134(1547)
To validate a reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) assay to detect SARS-CoV-2 in saliva in two independent Aotearoa New Zealand laboratories.An RT-qPCR assay developed at University of Illinois Urbana-Champaign, USA,
Autor:
Xinjie Xu, Emma Huxley, Sally Jeffries, Amanda Dixon-McIver, Min Fang, Tracy Tucker, Gordana Raca, Patrick A. Lennon, M. Anwar Iqbal, Marilyn L. Slovak, Patricia T. Greipp, Jennelle C. Hodge, Rashmi Kanagal-Shamanna, Ashwini Yenamandra, Fabiola Quintero-Rivera, Christine R. Bryke, Shashi Shetty
Publikováno v:
Cancer Genetics. :197-217
Multiple studies have demonstrated the utility of chromosomal microarray (CMA) testing to identify clinically significant copy number alterations (CNAs) and copy-neutral loss-of-heterozygosity (CN-LOH) in myeloid malignancies. However, guidelines for
Publikováno v:
Cancer Genetics. :1-9
Plasma cell disorders (PCD) range from benign to highly malignant disease. The ability to detect risk-stratifying aberrations based on cytogenetic and molecular genetic assays plays an increasing role in therapeutic decision making. In this study, 58
Autor:
Joanne Traeger-Synodinos, Christian Babbs, Amanda Dixon-McIver, Shiwangini Kumar, Joanne Slater, Veronica J. Buckle, Marjolein Kriek, Sharon W. Horsley, Paul Ooijevaar, Douglas R. Higgs, Cornelis L. Harteveld, Jill M. Brown, Evie Maifoshie
BackgroundSporadic deletions removing 100s-1000s kb of DNA, and variable numbers of poorly characterised genes, are often found in patients with a wide range of developmental abnormalities. In such cases, understanding the contribution of the deletio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20d5a42dcf5a82d31fc9902b28c8043e
Autor:
Mark J. McKeage, Daniel Ng, Amanda Dixon‐McIver, Donald R. Love, Karen L. Sheath, George Laking, Mark Elwood, Richard Sullivan, Prashannata Khwaounjoo, Christopher Lewis, Nicola Kingston, Laird Cameron, Philip Shepherd, Magreet Strauss, Sandar Tin Tin
Publikováno v:
Internal medicine journalReferences. 50(6)
BACKGROUND Lung cancer is a major cause of death in New Zealand. In recent years, targeted therapies have improved outcomes. AIM To determine the uptake of anaplastic lymphoma kinase (ALK) testing, and the prevalence, demographic profile and outcomes
Autor:
Paul Oei, Phillip Shepherd, Loretta Sioson, John Turchini, Amanda Dixon-McIver, Anthony J. Gill, Adele Clarkson, Juliana Andrici, Christopher W. Toon, Nicole Watson, Daniel Ng
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 25(7)
Anti-epidermal growth factor receptor-targeted therapy is only indicated in RAS wild-type colorectal carcinomas (CRCs). It is recommended that both NRAS and KRAS mutation testing to be performed before a CRC is considered RAS wild-type. Given that mu
Autor:
Amanda Dixon-McIver, Matthew L. Smith, T. Andrew Lister, Ama Z. S. Rohatiner, J. A. L. Amess, Michael J. Neat, Maxine Cambal-Parrales, Jennifer Snaddon, Rachael Arch, Jude Fitzgibbon
Publikováno v:
Genes, Chromosomes and Cancer. 37:72-78
CEBPA encodes the transcription factor C/EBPα and is specifically up-regulated during granulocytic differentiation. The gene is mutated in approximately 20% of patients with acute myeloid leukemia (AML) FAB type M2 and occurs in the absence of the t
Publikováno v:
Cancer Genetics. :44
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 667
The protocol reported in this chapter describes a method for the detection and spatial localisation of microRNAs (miRNAs) in cryopreserved primary leukaemic suspension cells using digoxigenin (DIG)-labelled, Locked Nucleic Acid (LNA)-modified probes,